摘要 |
This invention relates to novel compounds useful in the treatment of diseases associated with TRPV4 channel receptor. More specifically, this invention relates to certain substituted amino-azepines, according to Formula I or pharmaceutically acceptable salts, hydrates, or solvates thereof, wherein: R<SUP>1 </SUP>is aryl optionally substituted with CN, NO<SUB>2</SUB>, halogen or H; R<SUP>2 </SUP>is H, C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl, C<SUB>3</SUB>-C<SUB>7 </SUB>cycloalkyl, or C<SUB>3</SUB>-C<SUB>7 </SUB>heterocycloalkyl; R<SUP>3 </SUP>is H, OH, O-C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl, SH, S-C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl, or F; R<SUP>4 </SUP>is H, C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl R<SUP>5 </SUP>is iso-butyl, cyclohexylmethyl, or cyclopentylmethyl; and R<SUP>6 </SUP>is aryl, heteroaryl.
|